ESR1 and breast carcinoma: The observed differences can be attributed to inherent molecular distinctions between the two distinct breast cancer cell lines; for instance, MCF7 cells are ER+ (estrogen receptor +), whereas MDA-MB-231 cells are ER- (estrogen receptor −).